Immune Oncology Program
Case Comprehensive Cancer Center
My primary interest is in studying the applications of immunotherapeutic agents in the management of thoracic malignancies and understanding some of the resistance mechanisms to the same. I am also interested in biomarker discovery to predict response/ resistance to immunotherapy and associated toxicities.
Taussig Cancer Institute